![]() |
|
|
Vol. 29, Issue 11, 1389-1395, November 2001
Department of Medicinal Chemistry, University of Washington,
Seattle, Washington
A series of 1"-mono-, di-, and trifluorinated analogs of
propranolol and related steric congeners was prepared, and their metabolism was examined with recombinant-expressed CYP1A2. The structural changes in this series of compounds, principally added fluorines and methyl groups in the 1"-position of the
N-isopropyl group, provided compounds that varied in
pKa by more than 5 log units, in log D by 3 log units, and in size of the added substituents. N-Dealkylation and aromatic hydroxylation (formation of
the 4'- and 5'-regioisomers) were catalyzed by CYP1A2. Correlations of the metabolic kinetic parameters Km and
catalytic efficiency
(kcat/Km) with
physicochemical properties pKa and log D
showed that increased lipophilicity (higher log D values) was
associated with increased affinity (lower
Km) and increased catalytic efficiency for
CYP1A2. Comparison of log Km and log
kcat/Km with
pKa showed that the less basic analogs had
higher affinities and increased catalytic efficiencies. The changes
associated with pKa reflect increased lipid
partitioning of substrate (increased log D) caused by an increase in
the proportion of nonionized substrate. Increased steric bulk in the
N-substituent alone did not decrease substrate affinity
for CYP1A2 but did increase the amount of aromatic hydroxylation versus
N-dealkylation. Removal of the hydroxyl group from the propanolamine side chain of propranolol resulted in a similar change in
regioselectivity of metabolism.
This article has been cited by other articles:
![]() |
G. Tai, L. J. Dickmann, N. Matovic, J. J. DeVoss, E. M. J. Gillam, and A. E. Rettie Re-engineering of CYP2C9 to Probe Acid-Base Substrate Selectivity Drug Metab. Dispos., October 1, 2008; 36(10): 1992 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Upthagrove and W. L. Nelson Importance of Amine pKa and Distribution Coefficient in the Metabolism of Fluorinated Propranolol Derivatives. Preparation, Identification of Metabolite Regioisomers, and Metabolism by CYP2D6 Drug Metab. Dispos., November 1, 2001; 29(11): 1377 - 1388. [Abstract] [Full Text] [PDF] |
||||